Intriguingly, our recent study demonstrated that JFK suppresses hepatic lipid catabolism and exacerbates the development of obesity and non-alcoholic fatty liver disease (NAFLD) by destabilizing ING5. The gene discussed is FBXO42; the disease is metabolic dysfunction-associated steatotic liver disease.